Literature DB >> 11748057

Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats.

Takehisa Abe1, Yoshimi Ohga, Nobuoki Tabayashi, Shuichi Kobayashi, Susumu Sakata, Hiromi Misawa, Tsuyoshi Tsuji, Hisaharu Kohzuki, Hiroyuki Suga, Shigeki Taniguchi, Miyako Takaki.   

Abstract

To gain insight into the pathogenesis of diabetic cardiomyopathy, we investigated cardiac function in terms of the coupling of left ventricular mechanical work and the energetics in Otsuka Long-Evans Tokushima Fatty rats, which are well known as a model of type 2 diabetes mellitus (DM). Neither left ventricular systolic function and mean coronary flow nor coronary flow reserve differed even in late DM rats. The amount of oxygen required for mechanical work and contraction was unaltered, although myosin isozyme was finally transformed from V(1) to V(3). The maximum pacing rate was decreased from 300 to 240 beats/min, and the left ventricular relaxation rate was significantly (P < 0.05) slower only in late DM rats, resulting in decreased oxygen consumption per minute for total Ca(2+) handling in excitation-contraction coupling mainly consumed by sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2) without significant changes in basal metabolism or in mitochondrial oxidative phosphorylation. The protein level of SERCA2 in membranes was significantly (P < 0.001) lower in severe DM rats. We conclude that the only lusitropic dysfunction due to the depressed expression of SERCA2 is related to generating diabetic cardiomyopathy even in the present type 2 diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748057     DOI: 10.1152/ajpheart.2002.282.1.H138

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  35 in total

1.  Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Authors:  Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

2.  Evaluation of left ventricular mechanical work and energetics of normal hearts in SERCA2a transgenic rats.

Authors:  Guo-Xing Zhang; Koji Obata; Daisuke Takeshita; Shinichi Mitsuyama; Tamiji Nakashima; Akio Kikuta; Masumi Hirabayashi; Koichi Tomita; Roland Vetter; Wolfgang H Dillmann; Miyako Takaki
Journal:  J Physiol Sci       Date:  2012-03-01       Impact factor: 2.781

Review 3.  Diabetes and the risk of heart failure.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2011-10-13       Impact factor: 3.179

4.  Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.

Authors:  Véronique A Lacombe; Serge Viatchenko-Karpinski; Dmitry Terentyev; Arun Sridhar; Sitaramesh Emani; John D Bonagura; David S Feldman; Sandor Györke; Cynthia A Carnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-29       Impact factor: 3.619

5.  Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.

Authors:  T Hayashi; K Sohmiya; A Ukimura; S Endoh; T Mori; H Shimomura; M Okabe; F Terasaki; Y Kitaura
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 6.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

7.  Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats.

Authors:  Shaimaa S El-Sayed; Mohamed N M Zakaria; Rasha H Abdel-Ghany; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2016-04-29       Impact factor: 4.432

8.  Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Elisa T Lee; James M Galloway; Ana Barac; Julio A Panza; Barbara V Howard
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

Review 9.  [Diabetic cardiopathy: pathogenesis, diagnosis and therapy].

Authors:  C Tschöpe; H P Schultheiss
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

10.  Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.

Authors:  Ioannis Karakikes; Maengjo Kim; Lahouaria Hadri; Susumu Sakata; Yezhou Sun; Weijia Zhang; Elie R Chemaly; Roger J Hajjar; Djamel Lebeche
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.